Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: Implications for multiple sclerosis
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Axonal damage is a correlate for increasing disability in multiple sclerosis. Animal models such as experimental autoimmune encephalomyelitis (EAE) may help to develop better therapeutical neuroprotective strategies for the human disease. Here we investigate the pattern of axonal injury in murine myelin oligodendrocyte glycoprotein peptide 35-55 (MOG) induced EAE. Inflammatory infiltration, axonal densities and expression of amyloid precursor protein (APP), neurofilaments (SMI31 and 32) as well as expression of sodium channels were quantified in lesions, the perilesional area and normal appearing white matter (NAWM). Quantification of T cells and macrophages revealed a significant reduction of inflammatory infiltration at later disease stages despite an increase of demyelinated areas and persistent clinical disability. In lesions, axonal density was already significantly reduced early and throughout all investigated disease stages. A significant axonal loss was also seen in the grey matter and at later time points in the perilesion as well as NAWM. Numbers of axons characterized by non-phosphorylated neurofilaments and re-distribution of sodium channels 1.2 and 1.6 increased over the course of MOG-EAE whilst APP positive axons peaked at the maximum of disease. Finally, double-labeling experiments revealed a strong colocalization of sodium channels with APP, neurofilaments and the axonal nodal protein Caspr, but not glial and myelin markers in actively demyelinating lesions. In summary, progressive axonal loss distant from lesions is mainly associated with changes in neurofilament phosphorylation, re-distribution of sodium channels and demyelination. This axonal loss is dissociated from acute inflammatory infiltration and markedly correlates with clinical impairment. Consequently, therapeutic intervention may be promising at early stages of EAE focusing on inflammation, or later in disease targeting degenerative mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Gold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017 · cited 1×
“Our data underscore the value of MOG-EAE in C57BL/6 mice as a model closely mimicking neurodegenerative changes during autoimmune demyelination (Gold et al., 2006).”
BackgroundSelf-citationAcute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898 · cited 6×
“While histopathologic staining for amyloid precursor protein (APP) as a marker revealed that acute axonal injury in MS is already extensive early (Bitsch et al., 2000; Kuhlmann et al., 2002), imaging studies also point at a critical role of axonal loss for disease progression and accumulation of…”
BackgroundMethodInfluentialStys, P., Waxman, S., & Ransom, B. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00430.1992 · Cited by 662
Bjartmar, C., Wujek, J. R., & Trapp, B. D. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00069-2 · Cited by 573 · cited 1×
“…disability is well in line with the concept that in autoimmune demyelination, inflammatory processes may trigger neurodegenerative processes which at some point continue independently from the immune attack (for review see Bjartmar et al. (2003); Bjartmar and Trapp (2001); Trapp et al. (1999)).”
BackgroundPierce, J., Trojanowski, J., Graham, D., Smith, D., & McIntosh, T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01083.1996 · Cited by 239 · cited 1×
“APP is a well characterized marker for acute axonal injury in neurodegenerative diseases, but also MS (Kuhlmann et al., 2002; Pierce et al., 1996).”
BackgroundMerkler, D. (2006) · Brain · doi:10.1093/brain/awl135 · Cited by 222 · cited 1×
“After immunization with recombinant MOG, axonal damage was observed in the white matter of marmoset monkeys (Boretius et al., 2006) and rodents (Kornek et al., 2000) and in focal EAE models also in the cortex of susceptible rat strains (Merkler et al., 2006).”
BackgroundPapadopoulos, D., Pham-Dinh, D., & Reynolds, R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.033 · Cited by 115
Cited by
Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155
Self-citationPfeiffer, F., Schäfer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N., Deutsch, U., & Engelhardt, B. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0883-2 · Cited by 160
“As the degree of demyelination and/or axonal damage have been described as morphological correlates to increasing disability in MS and clinical severity of EAE [21], we undertook an effort to determine if ameliorated chronic EAE in Tie-2//TRE-claudin-1 C57BL/6 double transgenic mice was due to reduced CNS pathology.”
BackgroundInitiation and Progression of Axonopathy in Experimental Autoimmune Encephalomyelitis
Soulika, A. M., Lee, E., McCauley, E., Miers, L., Bannerman, P., & Pleasure, D. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3794-09.2009 · Cited by 158
“…causes axonal vacuolization and fragmentation and eventual spinal cord atrophy (Bannerman et al., 2005; Wang et al., 2005; Bannerman and Hahn, 2007; Herrero-Herranz et al., 2008; Jones et al., 2008), all features also seen in multiple sclerosis (Kornek et al., 2001; Evangelou et al., 2005; Miller…”
BackgroundBerard, J. L., Wolak, K., Fournier, S., & David, S. (2010) · Glia · doi:10.1002/glia.20935 · Cited by 147
“Several groups have induced chronic disease in C57BL/6 mice using MOG (Chabas et al., 2001; Herrero-Herranz et al., 2008; Slavin et al., 1998).”
Baxi, E. G., DeBruin, J., Tosi, D. M., Grishkan, I. V., Smith, M. D., Kirby, L. A., Strasburger, H. J., Fairchild, A. N., Calabresi, P. A., & Gocke, A. R. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3817-14.2015 · Cited by 103
Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice
Goldberg, J., Clarner, T., Beyer, C., & Kipp, M. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0595-5 · Cited by 96
“To estimate acute axonal damage in the region of interest, slides were processed for IHC using antiamyloid precursor protein (APP) antibodies, which is a frequently used marker to detect acute axonal damage (Bitsch et al. 2000; Herrero-Herranz et al. 2008).”
Slowik, A., Schmidt, T., Beyer, C., Amor, S., Clarner, T., & Kipp, M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12938 · Cited by 94
Synaptophysin Is a Reliable Marker for Axonal Damage
Gudi, V., Gai, L., Herder, V., Tejedor, L. S., Kipp, M., Amor, S., Sühs, K.-W., Hansmann, F., Beineke, A., Baumgärtner, W., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw114 · Cited by 87
Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach
Höflich, K. M., Beyer, C., Clarner, T., Schmitz, C., Nyamoya, S., Kipp, M., & Hochstrasser, T. (2016) · Brain Research · doi:10.1016/j.brainres.2016.08.048 · Cited by 46
“also been shown in MS animal models, such as experimental autoimmune encephalomyelitis (EAE) and toxin models (GilgunSherki et al., 2003; Herrero-Herranz et al., 2008; Irvine and Blakemore, 2006; 2008; Kornek et al., 2000; Lindner et al., 2009; Nikic et al., 2011; Woodruff and Franklin, 1999).”
InfluentialModelling MS: Chronic-Relapsing EAE in the NOD/Lt Mouse Strain
Dang, P. T., Bui, Q., D’Souza, C. S., & Orian, J. M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_378 · Cited by 35
Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis
Jokubaitis, V. G., Gresle, M. M., Kemper, D. A., Doherty, W., Perreau, V. M., Cipriani, T. L., Jonas, A., Shaw, G., Kuhlmann, T., Kilpatrick, T. J., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-32 · Cited by 31
Ayoub, S. S., Wood, E. G., Hassan, S.-U., & Bolton, C. (2011) · Inflammation Research · doi:10.1007/s00011-011-0352-3 · Cited by 19
Rühling, S., Kramer, F., Schmutz, S., Amor, S., Jiangshan, Z., Schmitz, C., Kipp, M., & Hochstrasser, T. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1353-9 · Cited by 18
Sex-dependent treatment of chronic EAE with partial MHC class II constructs
Benedek, G., Chaudhary, P., Meza-Romero, R., Calkins, E., Kent, G., Offner, H., Bourdette, D., & Vandenbark, A. A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0873-y · Cited by 13
Metadata
- Authors
- Herrero-Herranz, E., Pardo, L. A., Gold, R., & Linker, R. A.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 30
- Issue
- 2
- Pages
- 162-173
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2147089471
- Cited by
- 124
- References
- 8
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.